Revenue and Profitability Trends
Tuticorin Alkali’s net sales have shown considerable volatility over the past seven years. After a peak in fiscal 2023, with net sales exceeding ₹500 crores, the company’s revenue moderated to just over ₹300 crores in fiscal 2025. This decline followed a sharp rise from a low base in fiscal 2021, when sales were under ₹70 crores. The fluctuations reflect the company’s operational challenges and market conditions in the commodity chemicals sector.
Operating profit margins have mirrored this volatility. The company posted negative operating margins from 2019 through 2021, with the nadir in fiscal 2021 showing an operating loss margin exceeding 80%. However, from fiscal 2022 onwards, Tuticorin Alkali reversed this trend, achieving positive operating margins above 20% in the latest fiscal year. This improvement is indicative of better cost control and operational efficiencies, despite a slight dip in sales.
Profit after tax (PAT) followed a similar pattern, with losses recorded consistently until fiscal 2022. The turnaround is evident in fiscal 2023 and 2024, with PAT margins stabilising near 20%, and earnings per share rising to over ₹5 in fiscal 2025. Exceptional items in fiscal 2025 contributed positively to profit before tax, further enhancing the bottom line.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
Cost Structure and Operating Efficiency
The company’s raw material costs have generally tracked revenue movements, peaking alongside sales in fiscal 2023 before easing in subsequent years. Power costs and employee expenses have increased steadily, reflecting inflationary pressures and operational scale. Notably, other expenses have remained substantial but stable, indicating consistent overheads.
Despite these costs, Tuticorin Alkali has managed to improve its gross profit margin from negative territory in earlier years to nearly 28% in fiscal 2025. This margin expansion underscores improved pricing power and cost management, critical in the commodity chemicals industry where margins are often tight.
Balance Sheet and Financial Position
The company’s balance sheet has strengthened markedly. Shareholders’ funds swung from a negative net worth position in fiscal 2022 to a positive ₹141 crores by fiscal 2025, reflecting accumulated profits and capital infusion. The book value per share improved from a negative figure to over ₹11, signalling restored investor confidence.
Long-term borrowings appeared only in fiscal 2025, amounting to ₹50 crores, while short-term borrowings increased but remain manageable relative to the company’s asset base. Total liabilities rose in line with asset growth, with total assets reaching over ₹520 crores in fiscal 2025, up from just ₹108 crores in fiscal 2021. This asset growth was supported by capital work in progress and investments, indicating ongoing expansion and modernisation efforts.
Cash Flow and Liquidity
Cash flow from operating activities has been inconsistent, with a negative outflow recorded in fiscal 2025 after positive inflows in prior years. Investing activities have consistently absorbed cash, reflecting capital expenditure and asset acquisitions. Financing activities in fiscal 2025 provided significant inflows, likely linked to new borrowings and capital raising, balancing the cash position. The company’s cash and bank balances remain minimal, highlighting a focus on utilising funds for growth rather than liquidity hoarding.
Holding Tuticorin Alkali from Commodity Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Outlook and Investor Considerations
Tuticorin Alkali’s historical performance reveals a company that has navigated through significant financial distress to achieve a robust recovery. The turnaround is evident in improved profitability, strengthened equity base, and expanding asset base. However, the company’s reliance on borrowings and fluctuating cash flows suggests that investors should monitor liquidity and debt servicing closely.
Given the volatile nature of the commodity chemicals sector, maintaining operational efficiencies and managing input costs will be crucial for sustaining profitability. The company’s recent capital investments may position it well for future growth, but execution risks remain. Investors should weigh these factors alongside peer comparisons and sector dynamics when considering exposure to Tuticorin Alkali.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
